Aethlon Medical, Inc. (OTC:AEMD) announced that it has appointed Douglas Taylor to join the Science Advisory Board of Exosome Sciences, Inc(ESI). Dr. Taylor is known for his discovery of tumor-secreted exosomes, and is a notable author on the subject. ESI was recently formed by Aethlon Medical.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter
Aethlon Medical focuses primarily on the applications of the Hemopurifier platform technology. The hemopurifier is designed to reduce the presence of infectious viruses from human blood. Other wholly owned subsidiaries of the company include Aethlon, Inc., Cell Activation, Inc., Syngen Research, Inc., and Hemex, Inc.
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Us
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
